CF PharmTech, Inc. (HKG:2652)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
6.06
+0.31 (5.30%)
Oct 9, 2026, 4:08 PM HKT

CF PharmTech Cash Flow Statement

Millions CNY. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-6.792.4921.0931.73-49.4-131.73
Depreciation & Amortization
72.967.2258.8552.9638.227.9
Other Amortization
1.31.31.341.20.691.9
Loss (Gain) From Sale of Assets
0.040.060.630.390.810.01
Asset Writedown & Restructuring Costs
------0.3
Loss (Gain) From Sale of Investments
13.382-7.05-8.68-7.99-13.35
Loss (Gain) on Equity Investments
1.350.170.070.1--
Stock-Based Compensation
0.858.497.8216.6815.9214.24
Provision & Write-off of Bad Debts
-----0.06
Other Operating Activities
4.01-7.191.82-8.22-27.41-4.86
Change in Accounts Receivable
-126.44-137.57-25.556.39-8.26-3.38
Change in Inventory
-11.778.8-12.97-10.66-8.51-15.99
Change in Accounts Payable
9.852.427.430.18-5.9731.27
Change in Unearned Revenue
31.11-3.45-3.5218.59-0.42-
Change in Other Net Operating Assets
2.8-55.0346.515.6497.81-
Operating Cash Flow
-7.43-110.396.46116.2945.47-156.69
Operating Cash Flow Growth
---17.05%155.77%--

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-155.79-112.66-167.66-114.64-91.19-91.25
Sale of Property, Plant & Equipment
0.46-----
Sale (Purchase) of Intangibles
-24.67-38.47-32.99-23.7-15.74-
Investment in Securities
-21.7428.9273.1714.76-34375.92
Other Investing Activities
6.951.6314.05-4.08-10.516.4
Investing Cash Flow
-194.79-120.58-113.44-127.65-151.42301.06

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Long-Term Debt Issued
-88.8454.820--
Long-Term Debt Repaid
--23.4-5.78-3.55-4.01-
Lease Payments
-3.63-3.01-4.73-3.55-4.01-
Net Debt Issued (Repaid)
98.3665.4449.0216.45-4.01-
Issuance of Common Stock
554.79554.79----
Repurchase of Common Stock
-120.49-2.09----
Other Financing Activities
-52.99-49.94-20.33-8.58-1.4-4.5
Financing Cash Flow
479.68568.2128.697.88-5.41-4.5

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Foreign Exchange Rate Adjustments
-15.09-4.38-0.39-0.742.92-1.75
Net Cash Flow
262.37332.9611.33-4.23-108.45138.11

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
-163.23-222.96-71.21.65-45.72-247.95
Free Cash Flow Growth
------
Free Cash Flow Margin
-37.37%-51.55%-11.72%0.30%-13.10%-590.55%
Free Cash Flow Per Share
-0.41-0.59-0.190.00-0.12-
Levered Free Cash Flow
--288.95-97.6145.97-135.42-207.07
Unlevered Free Cash Flow
--287.37-96.4946.07-135.32-206.98
Free Cash Flow After Leases
-166.85-225.97-75.94-1.9-49.73-247.95

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Interest Paid
3.152.361.52---
Cash Income Tax Paid
------15.79
Change in Working Capital
-94.46-184.8211.8930.1474.65-50.57